Retinal neuroprotective effects of flibanserin, an FDA-Approved dual serotonin receptor agonist-antagonist

Aaron S. Coyner, Renee C. Ryals, Cristy A. Ku, Cody M. Fischer, Rachel C. Patel, Shreya Datta, Paul Yang, Yuquan Wen, René Hen, Mark E. Pennesi

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Retinal neuroprotective effects of flibanserin, an FDA-Approved dual serotonin receptor agonist-antagonist'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds